Metraipolis › archive › dc_7e7fc867f920

CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42292392
DOI
10.3389/fimmu.2026.1839064
License (as archived)
solo-consultazione
Archived
2026-11-01T05:04:12.336Z
SHA-256 of the archived text
b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed
Stable URL of this page
https://metraipolis.com/documento/dc_7e7fc867f920

How to cite

CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392 — Europe PMC (en), https://europepmc.org/article/MED/42292392 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e7fc867f920 (Metraipolis archive dc_7e7fc867f920, sha256 b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed)
BibTeX
@misc{dc7e7fc867f920,
  title = {CRISPR-screen informed engineered T cell therapies — Europe PMC PMID:42292392},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42292392},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e7fc867f920; sha256 b756296a46bde33313655ed036e63a8055934a8f394f94be1653ede69963f9ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42292392. Agents can read the archived copy with the MCP tool read_document.